Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $9.75, but opened at $9.41. Veradigm shares last traded at $9.41, with a volume of 20 shares trading hands.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the stock. TD Cowen dropped their price target on shares of Veradigm from $26.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, May 28th. StockNews.com initiated coverage on Veradigm in a research note on Sunday. They issued a "hold" rating on the stock. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Veradigm currently has an average rating of "Hold" and a consensus target price of $12.00.
Get Our Latest Analysis on Veradigm
Veradigm Trading Up 1.5 %
The stock's 50 day simple moving average is $9.66 and its 200 day simple moving average is $8.88.
Hedge Funds Weigh In On Veradigm
Several large investors have recently modified their holdings of MDRX. Innealta Capital LLC acquired a new stake in Veradigm during the second quarter valued at approximately $38,000. TFO Wealth Partners LLC lifted its stake in Veradigm by 105,280.0% during the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker's stock worth $52,000 after purchasing an additional 5,264 shares during the last quarter. Meadow Creek Wealth Advisors LLC acquired a new position in Veradigm in the first quarter worth $83,000. Forest Hill Capital LLC bought a new stake in Veradigm during the fourth quarter valued at $210,000. Finally, Aigen Investment Management LP acquired a new stake in shares of Veradigm during the fourth quarter worth $231,000.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
